In contrast, αMHC promoter-driven overexpression of ACE [28] or an engineered fusion protein designed to directly release Ang II [29] in cardiomyocytes did not result in ventricular hypertrophy despite of greater increases in cardiac Ang II level compared with the above mentioned study [27]. The gene discussed is ACE; the disease is cardiac hypertrophy.